Physician profile
Matthew Bower
NPI 1912115874
$22,403.53
in general payments reported to CMS, 2019-2025
9 companies · $211 in 2025
The $211 reported for 2025 was less than what a typical Surgical Oncology provider received nationally (typical 2025 total: $288).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $153 · 2022: $12.03 · 2023: $6,265 · 2024: $25.45 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $6,209 · Food and Beverage: $292.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $6,209.00 |
| Food and Beverage | $292.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $21,946.43 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Elucent Medical | $157.27 | 2025 | |
| Integra Lifesciences Corporation | $153.00 | 2020 | |
| Tactile Systems Technology INC | $34.70 | 2022-2023 | Entre Plus, Flexitouch Plus |
| Ethicon US, LLC | $33.14 | 2023 | Surgicel Nu-Knit, Harmonic, Enseal |
| Genentech USA, INC. | $31.60 | 2025 | Ocrevus Zunovo |
| Janssen Pharmaceuticals, INC | $25.45 | 2024 | Xarelto |
| Hologic Sales and Service, LLC | $21.94 | 2025 | Magtrace |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.